“…We used a panel of 19 chromosome-i-specific DNA probes (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22), and the order of these probes was determined by genetic linkage in the Centre d'Etude du Polymorphisme Humain reference panel families (10). Of these probes, eight define known gene loci-proatriodilatin (PND) (11), a-fucosidase (FUCAl) (12), the protooncogene c-fgr (FGR) (13), the protooncogene L-myc (MYCL) (14), a-amylase (AMY1) (15), ,3 nerve growth factor (NGFB) (16), anti-thrombin III (AT3) (17), and renin (REN) (18); two probes define chromosome-i-specific repetitive sequences-D1Z2 (19) and D1S57 (20); seven probes were isolated from a flow-sorted chromosome 1 library (D1S15, D1S16, D1S17, D1S18, D1S19, D1S21, and D1S22) (10), and two probes define anonymous DNA sequences-CRI-L336 (D1S47) (21) and D1S2 (22). A locus is considered informative for a particular patient when the constitutional DNA from that patient displays two different alleles (i.e., heterozygosity at that locus).…”